title: Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin.
abstract: Regulation of vascular homeostasis depends upon collaboration between cells of the vessel wall and blood coagulation system. A direct interaction between integrin alphaVbeta3 on endothelial cells and smooth muscle cells and prothrombin, the pivotal proenzyme of the blood coagulation system, is demonstrated and activation of the integrin is required for receptor engagement. Evidence that prothrombin is a ligand for alphaVbeta3 on these cells include: (a) prothrombin binds to purified alphaVbeta3 via a RGD recognition specificity; (b) prothrombin supports alphaVbeta3-mediated adhesion of stimulated endothelial cells and smooth muscle cells; and (c) endothelial cells, either in suspension and in a monolayer, recognize soluble prothrombin via alphaVbeta3. alphaVbeta3-mediated cell adhesion to prothrombin, but not to fibrinogen, required activation of the receptor. Thus, the functionality of the alphaVbeta3 receptor is ligand defined, and prothrombin and fibrinogen represent activation- dependent and activation-independent ligands. Activation of alphaVbeta3 could be induced not only by model agonists, PMA and Mn2+, but also by a physiologically relevant agonist, ADP. Inhibition of protein kinase C and calpain prevented activation of alphaVbeta3 on vascular cells, suggesting that these molecules are involved in the inside-out signaling events that activate the integrin. The capacity of alphaVbeta3 to interact with prothrombin may play a significant role in the maintenance of hemostasis; and, at a general level, ligand selection by alphaVbeta3 may be controlled by the activation state of this integrin.
authors.affiliation: Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
authors.forename: T V
authors.initials: TV
authors.lastname: Byzova
authors.forename: E F
authors.initials: EF
authors.lastname: Plow
mesh_terms: D000244:Adenosine Diphosphate / Q000494:pharmacology; D001011:Aorta; D002154:Calpain / Q000037:antagonists & inhibitors / Q000502:physiology; D003571:Cytochalasin B / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology*; D005340:Fibrinogen / Q000378:metabolism; D006487:Hemostasis; D006706:Homeostasis; D006801:Humans; D008345:Manganese / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000502:physiology; D011516:Prothrombin / Q000378:metabolism*; D019030:Receptors, Vitronectin / Q000378:metabolism*; D015398:Signal Transduction; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
chemical_list: D009842:Oligopeptides; D019030:Receptors, Vitronectin; D003571:Cytochalasin B; D008345:Manganese; D000244:Adenosine Diphosphate; D011516:Prothrombin; D005340:Fibrinogen; C058161:glycyl-arginyl-glycyl-aspartyl-seryl-proline; D011493:Protein Kinase C; D002154:Calpain; D013755:Tetradecanoylphorbol Acetate